v3.25.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 2 Months Ended 3 Months Ended
Mar. 31, 2024
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (149,906) $ (18,009,527)
Adjustments to reconcile net loss to net cash used in operating activities    
Allowances for credit losses 1,310,188
Day one loss on CPU Share Allocation Obligations 403,536
Change in fair value of CPU Share Allocation Obligations 2,491,598
Change in fair value of July Investment Agreement Derivative 12,572,249
Payment in kind - interest (474,050)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (25,000) (124,643)
Accounts payable (209,475)
Accrued expenses 87 (22,532)
Net cash used in operating activities (174,819) (2,062,656)
Cash flows from investing activities    
Issuance of notes receivable (373,737) (474,490)
Issuance of notes receivable, related party (1,680,000)
Net cash used in investing activities (373,737) (2,154,490)
Cash flows from financing activities    
Proceeds from issuance of member units 100
Proceeds from issuance of convertible preferred units 1,100,002 5,550,000
Payments for deferred transaction costs (215,000)
Net cash provided by financing activities 1,100,102 5,335,000
Net change in cash 551,546 1,117,854
Cash, beginning of period 2,614,710
Cash, end of period 551,546 3,732,564
Supplemental cash flow information:    
Taxes paid
Interest paid
Supplemental disclosure of noncash investing and financing activities:    
Fair value of CPU Share Allocation Obligations issued in connection with issuance of certain convertible preferred units 4,703,536
Deferred transaction costs included within accounts payable and accrued expenses 2,583,461
Convertible preferred units issued in exchange for subscription receivable $ 1,500,000